The proinflammatory anaphylatoxin C5a induces the release of prostanoids, ie, prostaglandins (PG) and thromboxane (TX), from the resident liver macrophages (Kupffer cells [KC]). Because KC themselves express prostanoid receptors, prostanoids-besides having paracrine functions-might regulate their own release in an autocrine loop. So far, such a possible feedback regulation has not been investigated systematically, probably because of methodological difficulties to measure newly synthesized prostanoids in the presence of added prostanoids. Here, after prelabeling of phospholipids with [
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rostanoids, ie, prostaglandins (PG) and thromboxane (TX), regulate cellular functions locally within an organ. Their synthesis in and release from certain cell types is increased by a variety of stimuli. It can be induced either acutely or transiently within minutes via G-protein-coupled receptors or tyrosine kinases and constitutive enzymes or slowly with some delay within hours mainly via tyrosine-kinase-coupled receptors and de novo expressed enzymes (Murakami and Kudo, 2001) . Prostanoids are known to act locally in a paracrine fashion on other cell types. In the perfused rat liver infusion of anaphylatoxins C5a and C3a (Püschel et al, 1996; Schieferdecker et al, 1999; Schieferdecker et al, 2001) or stimulation of hepatic nerves (Gardemann et al, 1992; Jungermann and Stümpel, 1999) in a first step rapidly elicited the release of PGF 2␣ , PGD 2 , PGE 2 , and TXA 2 from nonparenchymal cells such as Kupffer cells (KC) or hepatic stellate cells (HSC). In a second step, the prostaglandins then increased glucose output from hepatocytes to a maximum within 3 minutes (Iwai et al, 1988) by activating glycogen phosphorylase (Athari and Jungermann, 1989; Püschel et al, 1993 ). In contrast to recombinant rat C5a (rrC5a), which very rapidly stimulated prostanoid output from KC (Hespeling et al, 1995) , lipopolysaccharide (LPS) only slowly induced PGD 2 and PGE 2 release from these cells with a delay of several hours reaching maximal values after 24 hours or thereafter (Peters et al, 1990) . It is not known whether this slow prostaglandin release had any effect on prostanoid-mediated reactions of other liver cell types such as glucose release from hepatocytes (HC).
KC and HSC themselves express prostanoid receptors (Fennekohl et al, 1999 ). Thus, it seems possible that prostanoids in a feedback mode acutely regulate their own release from nonparenchymal cells and thus exert a fine control on prostanoid-modulated reactions of other liver cell types. So far, the putative feedback regulation of prostanoid synthesis by prostanoids has not been studied systematically neither in cell cultures nor in the intact organ. Only one study with cultured KC indicated that the slow and long-term LPS-elicited increase in PGD 2 and PGE 2 release after 24 hours was inhibited by PGE 2 (Peters et al, 1990 ). It was not investigated whether this feedback loop on slow increase in prostaglandin release could also be operative in the intact liver. The lack of more detailed information on short-term and long-term feedback inhibition of prostanoid synthesis by prostanoids is probably due to analytical difficulties. Prostanoids are normally quantified by ELISA, RIA, or HPLC. With immunoassays, and also with chromatographic techniques, it is impossible to measure the release of a given prostanoid when the same prostanoid is added to test its regulatory role. Very often it is equally impossible to determine the release of a given prostanoid when another prostanoid is applied in a relatively high concentration as a putative effector because of high immunological cross-reactivity or insufficient chromatographic separation.
It was the aim of the present study to investigate the feedback regulation of prostanoid synthesis by prostanoids and the possible consequences for the regulation of prostanoid-dependent glucose output in liver using cell cultures and the perfused organ. C5a and zymosan were chosen to acutely stimulate prostanoid release from KC. As a prerequisite for the study, a radiochemical method was developed allowing the measurement of released labeled prostanoids in the presence of higher levels of added unlabeled prostanoids given as putative effectors: KC were prelabeled with [1-
14 C]arachidonate and the released labeled prostanoids were separated by thin layer chromatography (TLC). It was found that C5a-, but not zymosan-induced prostanoid release from rat KC, was specifically inhibited by PGE 2 , most probably in a cAMP-mediated process via the G s protein-coupled PGE 2 receptors subtype 2 and 4 (EP2R and EP4R). This inhibition, which could also be demonstrated in the perfused liver as an impaired prostanoid overflow, led to a complete inhibition of C5a-induced, prostanoid-mediated glucose output from HC.
Results

Differences in rrC5a-and Zymosan-Induced Prostanoid Release from Cultured Kupffer Cells
To investigate possible feedback effects of prostanoids on their own release, first rrC5a-and zymosaninduced prostanoid secretion from cultured KC was characterized: as measured with RIA or ELISA techniques, rrC5a rapidly induced the release of PGD 2 , PGE 2 , and TXA 2 (measured as its stable decomposition product TXB 2 ) from these cells (Fig. 1A) . For PGD 2 and PGE 2 release, comparable results were obtained by RIA/ELISA (Fig. 1A) (Fig. 1B) . In contrast, TXA 2 -for unknown reasons-was only barely [ 14 C]labeled, supporting the finding that the synthesis of prostaglandins and TXA 2 are differently regulated (Dieter et al, 1989a) . TXA 2 could thus not be quantified by the radiochemical method.
The rrC5a-induced prostanoid secretion was maximal within the first 2 minutes (Fig. 1B) . Zymosan at this time point did not significantly stimulate prostanoid release; it caused a weak PGD 2 and PGE 2 output after 5 minutes, which was then still clearly lower than after rrC5a (Fig. 1B) . The release of PGD 2 , PGE 2 , and TXA 2 after zymosan was maximal after about 60 minutes; it then reached 10-fold higher levels than after rrC5a (Fig. 1A) .
Inhibition by PGE 2 and cAMP of rrC5a-, but Not of Zymosan-Induced PGD 2 , PGE 2 , and TXA 2 Release from Cultured Kupffer Cells PGE 2 at 10 M almost totally inhibited rrC5a-induced PGD 2 and PGE 2 release from 72 hour-cultured KC to 17% and 29%, respectively (unstimulated controls: 14% and 25% of rrC5a-stimulated values, respectively, determination by the radiochemical method) (Fig. 2) . PGE 2 at 1 M strongly reduced TXA 2 release to 36% (unstimulated cells: 17% of the rrC5a-stimulated value, determination by ELISA) (Fig. 2) ; higher PGE 2 concentrations could not be tested because of the high crossreactivity of PGE 2 in the TXB 2 ELISA (see Introduction, Discussion, and Materials and Methods). PGD 2 and the TXA 2 analog U46619 at 10 M, in contrast to PGE 2 , neither positively nor negatively influenced rrC5a-induced PGD 2 and PGE 2 release from the KC cultures (Fig. 2) . The effect of PGD 2 or U46619 on TXA 2 release could not be measured for technical reasons (see above).
Not only in KC, but also in 48 hour-cultured HSC, PGE 2 at 1 M clearly reduced C5a-induced PGD 2 output to 27 Ϯ 12% (n ϭ 3, p Ͻ 0.05), whereas the TXA 2 analog U46619 even at 10 M had no influence (86 Ϯ 7%; n ϭ 3, not significant) (data not shown). These findings with HSC indicate, that the inhibitory effect of PGE 2 on prostanoid release was specific for the prostaglandin, ie, PGE 2 , but not for the cell type. Surprisingly, PGE 2 did not significantly influence PGD 2 , PGE 2 , and TXA 2 release from KC induced by zymosan at 0.5 mg/ml (Fig. 3) . Also with a lower zymosan concentration of 0.1 mg/ml, which induced prostanoid synthesis submaximally to a similar extent as rrC5a, PGE 2 failed to reduce prostanoid release (data not shown). Thus, the inhibition of prostanoid synthesis by PGE 2 was also specific for the stimulus, ie, for C5a rather than for zymosan.
Because the EP2R and EP4R, which are expressed by KC (Fennekohl et al, 1999) , are coupled to G sproteins enhancing intracellular cAMP levels, the effect of CPT-cAMP (a membrane-permeable and stable derivative of cAMP) on rrC5a-and zymosaninduced prostanoid release was investigated. CPTcAMP (100 M), like PGE 2 , reduced rrC5a-induced PGD 2 , PGE 2 , and TXA 2 release from KC to about 42%, 41%, and 44%, respectively (unstimulated controls: 14%, 25%, and 17% of the rrC5a-stimulated values, respectively, see Fig. 2 ) (Fig. 3) . This result strongly suggests that the inhibition of prostanoid release by PGE 2 was regulated via the EP2R or EP4R. Zymosaninduced prostanoid release was neither influenced by CPT-cAMP (Fig. 3) nor by another cAMP-analog, dibutyryl-cAMP (db-cAMP) (not shown). This confirmed that the inhibitory effect of the cAMP-analogs was specific for the stimulus C5a.
Inhibition by PGE 2 of rrC5a-Induced Prostanoid Release in Isolated Perfused Rat Livers
It was then investigated whether PGE 2 would also inhibit C5a-induced prostanoid release from KC and HSC in the intact liver and not only from the isolated Pestel et al nonparenchymal cells in culture ( Fig. 2 and data not shown). Prostanoids released in the intact organ have a dual fate: they will enter the HC via the prostaglandin transporter (Pucci et al, 1999) to be degraded there, and they will diffuse into the sinusoids to be removed from the organ with the blood stream. The resultant of prostanoid synthesis by the nonparenchymal cells and prostanoid uptake by the HC is prostanoid overflow into the hepatic vein.
In the perfused rat liver, PGE 2 lowered rrC5a-elicited prostanoid overflow when applied 2 minutes before rrC5a addition: it reduced PGD 2 and TXB 2 (the stable decomposition product of the actually released TXA 2 ) overflow to 20% and to 45%-from 68 to 13
Figure 1.
Kinetics of PGD 2 , PGE 2 , and TXA 2 release stimulated by rrC5a or zymosan in cultured Kupffer cells (KC). KC were cultured for 72 hours with medium changes every 24 hours. Newly formed prostanoids were determined by immunological (A) or radiochemical (B) techniques. If the latter method was to be applied, 0.5 Ci [
14 C]arachidonate were added for the last 20 hours before the experiment (B). KC were preincubated for 10 minutes in RPMI/1% penicillin-streptomycin (A) or in HEPES-buffered HBSS (B) and then stimulated with 1 g/ml rrC5a or 0.5 mg/ml zymosan. At the indicated time points, aliquots of the supernatants were shock-frozen, and prostanoid concentrations were determined later either immunologically by RIA (PGD 2 ) and ELISA (PGE 2 and TXB 2 as the stable decomposition product of the actually released TXA 2 ) (A) or radiochemically after ethylacetate extraction and separation by thin layer chromatography (TLC) (B). A, Shows increases in prostanoid release into the medium calculated as values of stimulated probes minus those of unstimulated controls. Note the different scales on the ordinates. Values are means Ϯ SEM of three independent experiments; * p Ͻ 0.05, ** p Ͻ 0.01 ϭ significant differences compared with zero time values (Student's t test for unpaired samples). At 0 minutes, absolute levels of released prostanoids were 0.23 Ϯ 0.02 pmol PGD 2 /g DNA, 0.07 Ϯ 0.01 pmol PGE 2 /g DNA, and 0.08 Ϯ 0.01 pmol TXA 2 /g DNA. B, Shows the release of [ 14 C]labeled PGD 2 and PGE 2 into the medium in pCi/10 6 KC. Note the logarithmic scales on the ordinates. Values are means Ϯ SEM of three independent experiments.
Figure 2.
Inhibition of rrC5a-induced PGD 2 , PGE 2 , and TXA 2 release by PGE 2 but not by PGD 2 or the TXA 2 analog U46619 in cultured KC. KC were cultured for 72 hours and prelabeled with [
14 C]arachidonate as described for Figure 1B . They were preincubated in HEPES-buffered HBSS for 10 minutes and then stimulated with 1 g/ml rrC5a with or without 10 M PGD 2 , U46619, or PGE 2 (1 M for measurement of TXA 2 release to minimize cross-reactivity in the TXB 2 ELISA). After 30 minutes, the supernatants were shock-frozen and prostanoid release was determined either by the radiochemical method (PGD 2 , PGE 2 ) or by ELISA (TXB 2 ). Values for rrC5a-stimulated KC were set equal to 100%. They are means Ϯ SEM of three to five independent experiments (numbers in parentheses); * p Ͻ 0.05, ** p Ͻ 0.01 ϭ significant differences compared with rrC5a-stimulated controls (Student's t test for unpaired samples). For better comparison, prostanoid release from unstimulated cells is indicated by a broken line. TXA 2 release in the presence of PGD 2 or U46619 could not be measured because of cross-reactivity of the TXB 2 ELISA with the respective prostaglandin. and from 24 to 11 pmol/g liver (AUC), respectively (Fig.  4 , upper-middle versus left panels), in agreement with the inhibitory actions on prostanoid release from cultured nonparenchymal cells. PGD 2 did not lower but even increased rrC5a-stimulated prostanoid overflow: PGD 2 enhanced rrC5a-elicited TXB 2 overflow (PGD 2 overflow in the presence of exogenous PGD 2 cannot be measured) by almost fourfold-from 24 to 95 pmol/g liver (AUC) (Fig. 4 , upper-right versus left panels). This unexpected increase in prostanoid overflow was probably due to a competitive inhibition by the high levels of exogenous PGD 2 of TXA 2 /TXB 2 uptake into the HC via the prostaglandin transporter. Similarly, also high levels of exogenous PGE 2 would competitively inhibit PGD 2 and TXA 2 /TXB 2 uptake into the hepatocytes via the prostaglandin transporter; thus, the inhibition by PGE 2 of rrC5a-dependent PGD 2 and TXB 2 overflow to only 20% and 45%, respectively (Fig. 4 , upper-middle versus left panels), probably reflects a much higher impairment of prostanoid release from the nonparenchymal cells.
Inhibition of Prostanoid Release by PGE
Inhibition by PGE 2 of rrC5a-Induced Prostanoid-Mediated Glucose Output and Flow Reduction in Isolated Perfused Rat Livers
In the perfused rat liver, rrC5a previously had been shown to increase glucose output from HC and to reduce flow via prostanoids released from KC and HSC . Therefore, it was finally studied whether PGE 2 could act as a feedback inhibitor in these prostanoid-mediated hepatic reactions. In the perfused rat liver, exogenous PGE 2 alone Inhibition of rrC5a-, but not of zymosan-induced prostanoid release by PGE 2 or cyclic AMP, in cultured KC. KC were cultured for 72 hours and prelabeled with [ 14 C]arachidonate as described for Figure 1B . They were preincubated in HEPES-buffered HBSS for 10 minutes and then stimulated with 1 g/ml rrC5a or 0.5 mg/ml zymosan with or without 10 M PGE 2 (1 M for measurement of TXA 2 release to minimize cross-reactivity in the TXB 2 ELISA) or 100 M CPT-cAMP. After 30 minutes, the supernatants were shock-frozen and prostanoid release was determined later either by the radiochemical method (PGD 2 , PGE 2 ) or by ELISA (TXB 2 ). Values for rrC5a-or zymosan-stimulated KC were set equal to 100%. They are means Ϯ SEM of three to five independent experiments (numbers in parentheses); * p Ͻ 0.05, ** p Ͻ 0.01 ϭ significant differences compared with rrC5a-or zymosan-stimulated controls (Student's t test for unpaired samples). For better comparison, prostanoid release from unstimulated cells is indicated by a broken line. Inhibition by PGE 2 , but not by PGD 2 , of rrC5a-induced prostanoid overflow as well as glucose release and flow reduction in isolated perfused rat livers. Isolated rat livers were perfused in a nonrecirculating manner with KrebsHenseleit bicarbonate buffer equilibrated with O 2 :CO 2 (19:1). After 30 minutes preperfusion, rrC5a was infused for 30 seconds to a final concentration of 1 g/ml. When indicated, PGE 2 or PGD 2 were applied to final inflow concentrations of 10 M starting 2 minutes before rrC5a addition over a total period of 6 minutes. In the fractionated effluate, PGD 2 and TXB 2 were determined by ELISA and RIA, respectively, and glucose in a standard assay with glucose dehydrogenase. Flow rate was measured by quantitating the effluate. Filled circles show effects of rrC5a in the absence (left panels) or presence (middle and right panels) of PGE 2 or PGD 2 , respectively; open circles show the actions of PGE 2 or PGD 2 alone. The alterations caused by rrC5a alone in the absence and those elicited by rrC5a in the additional presence of PGD 2 or PGE 2 are shown as hatched areas. Absolute values of the areas under the curves (AUC) (pmol/g, mol/g, or ml/g) are given numerically. Values are means Ϯ SEM of three independent experiments. Cannot be measured: PGD 2 overflow in the presence of PGD 2 cannot be measured by ELISA techniques.
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or PGD 2 alone, like rrC5a alone, increased glucose output and reduced flow (Fig. 4, lower panels) . When rrC5a was applied 2 minutes after PGE 2 , it did not cause an additional increase in glucose output and in flow reduction (Fig. 4 , lower-middle versus left panels); apparently, PGE 2 inhibited the rrC5a-elicited, prostanoid-mediated metabolic and hemodynamic effects. In contrast, when rrC5a was applied 2 minutes after PGD 2 , it caused an additional increase in glucose output and in flow reduction (Fig. 4 , lower-right versus left panels); apparently, PGD 2 did not reduce the rrC5a-elicited, prostanoid-mediated metabolic and hemodynamic changes. Moreover, in the presence of PGD 2 the rrC5a-dependent increase in glucose output and reduction of flow were greater than in its absence, ie, 3.3 versus 2.0 mol glucose/g liver and Ϫ1.7 versus Ϫ0.5 ml/g liver, respectively (Fig. 4 , lower-right versus left panels). These changes were in line with the enhanced rrC5a-dependent prostanoid overflow in the presence of PGD 2 reflecting a higher availability of prostanoids in the liver (Fig. 4 , upper-right panel).
Thus PGE 2 not only inhibited the rrC5a-elicited prostanoid release from nonparenchymal cells in culture ( Fig. 2 ) and in the perfused liver (Fig. 4 , upper panels), but it also impaired the rrC5a-dependent, prostanoid-mediated metabolic and hemodynamic reactions of the organ (Fig. 4, lower panels) .
Discussion
In the present study it was shown that PGE 2 , but not PGD 2 or TXA 2 , acutely inhibited the rapid C5a-elicited prostanoid release from rat KC and HSC in culture ( Fig. 2 and data not shown) and in the perfused rat liver (Fig. 4, upper panels) , and that this inhibitory action of PGE 2 could be mimicked by cAMP (Fig. 3) . Furthermore, it was found that PGE 2 or cAMP did not inhibit the rapid zymosan-stimulated prostanoid release (Fig. 3) . Finally, it was demonstrated that in the perfused rat liver, PGE 2 , but not PGD 2 , inhibited the short-term, C5a-induced prostanoid-mediated increase in glucose output and reduction of flow (Fig. 4 , lower panels).
Feedback Inhibition of Prostanoid Formation by PGE 2 : Analytical Difficulties
So far, no information on a possible short-term feedback regulation of prostanoid formation by prostanoids has been available. This is probably due to analytical difficulties. The basal or stimulated release of a given prostanoid from a cell cannot be measured in the presence of the same prostanoid added as a putative effector using standard ELISA and RIA or HPLC and TLC methods. Very often, with the standard techniques it cannot be measured either in the presence of higher levels of another effector prostanoid because of cross-reactivities in the immunological tests or insufficient separation. Only a few combinations of cellularly-synthesized and of added prostanoids can be analyzed at the given concentrations using immunoassays.
To study a possible short-term feedback regulation of prostanoid synthesis and release by prostanoids, a radiochemical analytical procedure was developed. Cellular phospholipids as prostanoid precursors were prelabeled with [1-14 C]arachidonate. The newly synthesized and released [ 14 C]labeled prostanoids were separated by TLC. Quantification of PGD 2 and PGE 2 by this radiochemical technique yielded results comparable with those obtained with the immunoassays (Fig. 1, A and B) . For unknown reasons, released TXA 2 was hardly labeled and could thus not be quantified by the radiochemical technique. However, the release of TXA 2 from the cultured cells resulting in accumulation of TXB 2 , the stable TXA 2 decomposition product in the media could be measured with a TXB 2 ELISA in the presence of up to 1 M PGE 2 because of a relatively low cross-reactivity of this immunoassay with PGE 2 (Figs. 2 and 3) . The release of TXA 2 in the perfused liver resulting in TXB 2 overflow could also be measured even at the high PGE 2 and PGD 2 inflow concentrations of 10 M, because more than 90% of a given prostanoid has been shown to be degraded during a single liver passage (Muschol et al, 1991; Tran-Thi et al, 1991) ; the same holds for PGD 2 overflow in the presence of the high PGE 2 inflow concentration of 10 M (Fig. 4, upper panels) .
Feedback Inhibition of Prostanoid Formation by PGE 2 : Specificity for the Prostanoid but Not for the Cell Type
RrC5a stimulated the release of PGD 2 , PGE 2 , and TXA 2 from cultured KC rapidly within the first 2 minutes (Fig. 1 ), in line with previous studies, which in addition showed an increase in PGF 2␣ release (Hespeling et al, 1995) . Only PGE 2 , but neither PGD 2 nor the TXA 2 analog U46619, acutely inhibited the C5a-induced PGD 2 and PGE 2 release from KC (Fig. 2) , analogous to the inhibition by PGE 2 , but not PGD 2 , of the slow and delayed prostanoid formation induced by LPS (Peters et al, 1990 ). CPT-cAMP had a similar effect on C5a-induced prostanoid release as PGE 2 (Fig. 3) . This strongly suggests that the short-term feedback inhibition of prostanoid release by PGE 2 was mediated by G s -coupled, cAMP-enhancing EP2R or EP4R present in KC (Fennekohl et al, 1999) . More direct evidence for the role of these PGE 2 receptor subtypes in the inhibition of C5a-induced prostanoid release from KC (Figs. 2 and 3 ) and glucose output from HC in the perfused liver (Fig. 4 , lower panels) would come from experiments investigating the effects of C5a on prostanoid release in cultured KC and on glucose output in the perfused liver in the presence of specific EP2R or EP4R antagonists; these, however, are not available so far. A mediation by cAMP of the effect of PGE 2 had also been proposed but not experimentally shown for LPS-induced prostanoid formation (Peters et al, 1990) .
PGD 2 , in contrast to PGE 2 , did not inhibit the C5a-induced prostanoid release from KC (Fig. 2) . This finding is in line with the very low expression of G s -coupled, cAMP-elevating PGD 2 receptors (DPR) in KC (Fennekohl et al, 1999) . The TXA 2 analog U46619 did not impair the C5a-elicited prostanoid formation in KC neither (Fig. 2) , in line with the observation that TXA 2 acts via G 0 -coupled TXA 2 receptors (TPR) (Fennekohl et al, 1999) , enhancing inositol-1,4,5-trisphosphate rather than cAMP.
The short-term inhibitory effect of PGE 2 on C5a-induced prostanoid release was not cell specific: also in HSC only PGE 2 , but not the TXA 2 analog U46619, reduced C5a-induced PGD 2 release to similar levels as in KC. Information on the cell specificity of the long-term inhibition by PGE 2 of LPS-induced prostanoid formation is not available.
Feedback Inhibition of Prostanoid Formation by PGE 2 : Specificity for the Stimulus
Only the C5a-, but not the zymosan-induced prostanoid release, was inhibited by PGE 2 and CPT-cAMP (Fig. 3) . This was not due to the higher amounts of prostanoids released after zymosan stimulation (Fig.  1) , because PGE 2 also failed to inhibit prostanoid release stimulated by zymosan concentrations, which enhanced prostanoid output to comparable levels as C5a (see Results, data not shown). In contrast to the present data, Dieter et al, 1989b showed a partial inhibition of zymosan-induced prostanoid release from KC by db-cAMP. These differences cannot be ascribed to differences in the experimental procedure, because neither preincubation with CPT-cAMP nor the use of db-cAMP-a membrane permeable, but with respect to CPT-cAMP, less stable derivative of cAMP-reduced zymosan-dependent PGD 2 release from KC (see Results, data not shown).
The differences in the kinetics (Fig. 1B ) and in the inhibition by PGE 2 or cAMP (Fig. 3) between C5a-and zymosan-induced prostanoid release implicate different intracellular signaling cascades and/or activation of different (iso-)enzymes used by the two stimuli. PGE 2 via cAMP could thus impair the signal transduction from the C5a receptor to the first major rate limiting enzyme of prostanoid synthesis, phospholipase A 2 (Decker, 1990) , or it could inhibit an isoenzyme of phospholipase A 2 specifically activated by the C5a-but not by the zymosan-stimulated signaling chain (Fig. 5) .
Feedback Inhibition of Prostanoid Formation by PGE 2 : Functional Significance in Liver
In the perfused rat liver, PGE 2 at an inflow concentration of 10 M strongly reduced PGD 2 and TXB 2 overflow into the hepatic vein (Fig. 4, upper-middle and left  panels) . This reduction of overflow was most probably due to a PGE 2 -dependent inhibition of PGD 2 and TXA 2 release mainly from KC (Figs. 2 and 3) and also from HSC (not shown) in line with the respective findings with the cultured nonparenchymal cells. A possible PGE 2 -dependent increase in PGD 2 and TXA 2 /TXB 2 uptake into the HC via the prostaglandin transporter contributing to the lowering of prostanoid overflow is highly unlikely.
The circulating concentrations of prostanoids are in the nanomolar range (Wernze et al, 1986 ). In the liver, locally in the space of Disse, the concentrations of prostanoids released from nonparenchymal cells were calculated to reach the 1 to 10 micromolar range within 1 minute after stimulation (Neuschäfer-Rube et al, 1993) . The short-term increase in glucose output and decrease in flow by exogenous prostaglandins in the perfused rat liver were found to be half-maximal at 3 to 8 micromolar levels of prostaglandins (Iwai et al, 1988) . In the present study, the PGE 2 -elicited inhibition of short-term prostanoid synthesis and release from nonparenchymal cells in isolated cells (Figs. 2  and 3 ) and in the perfused rat liver (Fig. 4) was shown to be effective in the same concentration range. Therefore, the acute feedback inhibition of prostanoid synthesis by PGE 2 should be a functionally relevant process.
Direct evidence for such a feedback loop being operative in the whole organ would be given by the use of specific blockers of cAMP-enhancing EP2R and EP4R; such blockers, however, are not available so far. Therefore, it was shown that exogenous PGE 2
Figure 5.
Feedback inhibition by PGE 2 of C5a-induced prostanoid release from KC limiting C5a-induced prostanoid-mediated glucose output and flow reduction in the liver (in part hypothesis). C5a increases the output of PGD 2 , PGE 2 , PGF 2␣ , and TXA 2 from KC. PGD 2 , PGE 2 , PGF 2␣ , and TXA 2 have paracrine effects on hepatocytes (HC) and sinusoidal endothelial cells (SEC) or hepatic stellate cells (HSC), respectively, such as an increase in glucose output and a decrease in flow. PGE 2 , in addition to its paracrine functions, reduces C5a-induced prostanoid release from KC in an autocrine manner. This negative feedback loop is mediated by the G s protein-coupled PGE 2 receptors subtype 2 or 4 (EP2R or EP4R) via an increase of cAMP. The target of cAMP action could be the signaling chain from the C5a receptor (C5aR) to phospholipase A 2 (PLA 2 ) or a PLA 2 isoenzyme specifically activated by C5a.
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prevented the C5a-elicited prostanoid-mediated increase in glucose output and decrease in flow (Fig. 4 , lower-middle and right panels).
In summary, these data indicate that PGE 2 impaired the C5a-elicited release of PGE 2 , PGD 2 , and TXA 2 from KC and HSC, and thus inhibited the C5a-induced, prostanoid-mediated glucose output from HC and flow reduction in perfused rat livers. Thus, PGE 2 could, via a negative feedback loop, prevent an overshoot of prostanoid-dependent defense reactions of the liver, such as the C5a-induced, prostanoiddependent glucose release (Fig. 5 ).
Materials and Methods
Animals
Male Wistar-Unilever rats (Winkelmann, Borchen, Germany), weighing 150 to 200 g for perfusion experiments, 300 to 350 g for isolation of KC, and 400 to 500 g for isolation of HSC were kept on a 12 hour day/night rhythm with free access to water and a standard rat diet (Ssniff, Soest, Germany) for at least 2 weeks before the experiment. Treatment of the animals followed the German Law on the Protection of Animals.
Materials
Pronase was obtained from Merck (Darmstadt, Germany), collagenase H and DNAse from Roche (Mannheim, Germany), and Nycodenz from Life Technologies (Eggenstein, Germany). Zymosan A from Saccharomyces cerevisiae and the TXA 2 analog U46619 were delivered by Sigma-Aldrich (Deisenhofen, Germany), PGD 2 and PGE 2 by Serva (Heidelberg, Germany), and chlorphenylthio-cAMP (CPTcAMP) and dibutyryl-cAMP (db-cAMP) by Roche. 14 C]arachidonate (activity 50 -62 mCi/mmol) were purchased from Amersham (Braunschweig, Germany). ELISAs for PGE 2 and TXB 2 were from R&D Systems (Wiesbaden-Nordenstadt, Germany), and silica gel plates (F1500, acid resistant) were from Schleicher & Schüll (Dassel, Germany). All other chemicals were of analytical grade and from commercial sources. Daltroban (BM 13.505: 4-[2-(4-chlorobenzenesulphonylamino)-ethyl] benzene-acetic acid) was kindly provided by Roche. RrC5a was prepared as previously described .
Isolation and Culture of Kupffer Cells
KC were isolated by combined pronase/collagenase perfusion and purified by density gradient centrifugation through 16.7% Nycodenz and subsequent counterflow elutriation using a Beckmann J-21 centrifuge with a Beckmann JE-6 elutriation rotor (Beckmann, München, Germany) (Brouwer et al, 1984) . 4*10 6 KC were plated on 35 mm culture dishes (Nunc, Wiesbaden, Germany) in RPMI 1640 (Biochrom, Berlin, Germany) supplemented with 30% newborn calf serum (PAA Laboratories, Cölbe, Germany) and 1% penicillin-streptomycin (Serva). KC were cultured for 72 hours, with medium changes every 24 hours, and were then Ͼ 99% pure as determined by phagocytosis of fluorescent latex beads (fluoresbrite, diameter 1 m; Polysciences, Eppelheim, Germany) (Shaw et al, 1984) and/or intracellular staining of added diaminobenzidine (Sigma-Aldrich) by endogenous peroxidases (Widman et al, 1972) .
Isolation and Culture of Hepatic Stellate Cells
HSC were obtained by Ca 2ϩ -free, EGTAsupplemented perfusion of the liver, followed by combined pronase/collagenase-digestion (Schieferdecker et al, 1997) . HSC were concentrated at the interphase of an 8.1% Nycodenz density gradient. 0.4*10 6 HSC were plated on 24 well culture dishes in RPMI 1640 supplemented with 30% newborn calf serum and 1% penicillin-streptomycin. HSC were cultured for 48 hours, with one medium change after 24 hours, and were then Ͼ 95% pure as determined by vitamin A autofluorescence (Suematsu et al, 1993) .
Cell Culture Experiments
For experiments up to 1 hour, KC or HSC were washed with and incubated in HBSS supplemented with 20 mM HEPES, pH 7.4; for longer experiments cells were kept in RPMI 1640 with 1% penicillinstreptomycin, pH 7.4. Cells were preincubated for 10 minutes at 37°C and then stimulated with rrC5a or zymosan at final concentrations of 1 g/ml (100 nM) and 0.5 mg/ml, respectively. When indicated, CPTcAMP (100 M), db-cAMP (100 M), or PGE 2 , PGD 2 , as well as the TXA 2 analog U46619 (10 M each for the detection of synthesized prostanoids by the radiochemical method, and 1 M each for the detection by RIA or ELISA), were added simultaneously with rrC5a or zymosan. Aliquots of the cell culture supernatants were shock-frozen in liquid nitrogen and stored at Ϫ20°C until determination of prostanoid concentrations.
Perfusion of Isolated Rat Liver
Livers were perfused in a nonrecirculating manner via the portal vein with a flow rate of about 4 ml/minutes/g liver with an erythrocyte-free Krebs-Henseleit bicarbonate buffer containing 5 mM glucose, 2 mM lactate, and 0.2 mM pyruvate, equilibrated with O 2 :CO 2 (19:1) at 37°C. After 30 minutes of preperfusion, livers were stimulated for 30 seconds with 1 g/ml rrC5a. In case of prostaglandin coinfusion, 10 M PGE 2 or PGD 2 were given over 6 minutes, starting 2 minutes before rrC5a infusion. Every minute, flow rates were determined by quantitating the effluent, and aliquots of the perfusate were taken for quantitation of glucose and prostanoid concentrations.
Biochemical Determinations
Glucose concentrations were measured with a commercial enzyme test kit using glucose dehydrogenase (granutest; Merck) (Banauch et al, 1975) . DNA content of cultured cells was determined by intercalation of bis-benzimide (Sigma-Aldrich), followed by fluorometric quantitation (Labarca and Paigen, 1980) . Prostanoid concentrations in the culture media or perfusion effluats were quantified without further purification with commercial RIAs (PGD 2 ) or ELISAs (PGE 2 or TXA 2 , which was determined as its stable decomposition product TXB 2 ). In the experiments for the investigation of feedback effects of added prostanoids, RIAs or ELISAs could not generally be applied because of high cross-reactivities of the immunoassays with the added prostanoids. In these cases, prostanoids were determined by the radiochemical method. Cellular phospholipids as prostanoid precursors were prelabeled by addition of 0.5 Ci [1-
14 C]arachidonate to KC cultures for 20 hours before the experiment. At the end of the experiment the newly formed [
14 C]labeled prostanoids were extracted from the cell culture supernatant with ethylacetate. They were then separated by thin layer chromatography (TLC) on silica plates with the organic phase of ethylacetate/water/ isooctane/acetate (110:100:50:20, v/v) (Hamberg and Samuelsson, 1966 
